Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.51
Data as of 3:59pm ET
 -0.28 / -3.19%
Today’s Change
6.12
Today|||52-Week Range
31.73
-44.85%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$87.5M

Company Description

Oramed Pharmaceuticals, Inc. is engaged in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides, such as insulin and vaccines. Its products are oral insulin and oral Exenatide capsules. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Contact Information

Oramed Pharmaceuticals, Inc.
Hi-Tech Park 2/5
Jerusalem -- 91390
P:(722) 566-0001
Investor Relations:
972547924438

Employees

Shareholders

Mutual fund holders3.38%
Individual stakeholders22.31%
Other institutional10.05%

Top Executives

Nadav KidronPresident, Chief Executive Officer & Director
Joshua HexterChief Operating Officer & VP-Business Development
Yifat ZommerChief Financial Officer, Secretary & Treasurer
Miriam KidronDirector, Chief Medical & Technology Officer
Ehud ArbitDirector-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.